FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559843329> ?p ?o ?g. }

• W2559843329 abstract "Abstract Abstract 4704 Background and aim of the study. Emerging trends emphasize the importance of both innate and adaptive immune system in the response against infections, in the pathogenesis of autoimmune diseases and graft-versus-host disease (GVHD). In the cross-talk between innate and adaptive immune system, pattern recognition receptors such as Toll-like receptors (TLRs) play a key role. TLRs recognize common protein, carbohydrate or DNA/RNA pattern motifs leading to signaling for cytokine production and T cell and dendritic cell maturation. These receptors may act as tuner of inflammatory and immunologic reactions. Very little is known about the expression and the function of TLRs in vivo in patients who underwent to allogeneic stem cell transplantation (SCT). The aim of this study was to evaluate the expression and the function of TLRs on lymphocytes and monocytes in relation to infection (CMV and HHV-6, especially) and the onset of GVHD. Patients and methods. The expression of TLRs on T cells and monocytes was analyzed by flow cytometry at day +30, +90, +180 after SCT and at the onset of GVHD. The expression of receptors for lipid-based pathogen-associated molecular patterns (PAMPs: TLR 1,2,4 and 6 surface receptors), receptors for nucleic acid based PAMPs (TLR 3,7,8 and 9 located in cytoplasmic compartments), TLR5 and, TLR10 (surface receptors) was evaluated as mean fluorescence intensity (MFI). Ex vivo induction of cytokines (TNFalpha, MCP1, IFNgamma, IL-10) by TLR ligands was analyzed in the cell supernatant by ELISA. Since the beginning of the study, we have analyzed data of 12 healthy donors and 14 patients. Median age was 46 years (range, 25–64) and 7 patients were male. Results. Acute GVHD developed in 7 patients. Patients without acute GVHD after SCT and healthy donors showed different MFI of TLR3 on T cells (5,8±1,4 vs 4,2±1,05 p=0,02), of TLR4 on monocytes (26,1±1,01 vs 15,8±4,9 p=0,004), and of TLR6 on T-lymphocytes (7,3±3,2 vs 4,6±1,1 p=0,02) and monocytes (27±12,1 vs 14,9±4,6 p=0,01). TLR3 expression was significantly decreased on T-lymphocytes and monocytes in patients with acute GVHD in comparison to those without GVHD (4,06±0,8 vs 5,8±1,4 p=0,02; 9,3±7,2 vs 38,02±30 p=0,04). The levels of TLR5 on T cells and monocytes were higher in patients with acute GVHD compared to healthy donors (8,4±2,1 vs 6,4±1,6 p=0,04; 54,2±20,2 vs 33,2±16,5 p=0,04). An increased induction of IFNgamma upon TLR1 ligand activation was observed in patients without GVHD in comparison to healthy donors and patients with GVHD (p=0,04). TLR6 ligand induced significantly the production of IFN gamma in patients with GVHD in comparison to controls and the other patients (p=0,03). Patients without GVHD showed a trend toward a decreased induction of MCP1 upon TLR4 ligand activation (p=0,07). The rate of infections (especially CMV reactivation), clinical and transplant characteristic were not significantly different between patients with and without GVHD. Conclusion In our study, a different expression profile of TLRs was found in healthy donors, in patients after SCT without acute GVHD and in those with GVHD. These results suggest that the innate immune response via TLRs activation could be involved in the development of GVHD. The assessment of a larger number of patients would be useful to understand the complex interplay between pathogens, self or non-self DNA and RNA and the immune system after SCT. Disclosures: Off Label Use: In Italy the use of azacitidine for Low-risk Myelodysplastic patients is off label. The use of azacitidine in our study is part of a Phase II clinical trial." @default.
• W2559843329 created "2016-12-16" @default.
• W2559843329 creator A5009276136 @default.
• W2559843329 creator A5015268079 @default.
• W2559843329 creator A5015623905 @default.
• W2559843329 creator A5016565948 @default.
• W2559843329 creator A5026698465 @default.
• W2559843329 creator A5028719318 @default.
• W2559843329 creator A5029820057 @default.
• W2559843329 creator A5030528628 @default.
• W2559843329 creator A5036597360 @default.
• W2559843329 creator A5038654360 @default.
• W2559843329 creator A5047806703 @default.
• W2559843329 creator A5047949241 @default.
• W2559843329 creator A5051875196 @default.
• W2559843329 creator A5060457186 @default.
• W2559843329 creator A5067333129 @default.
• W2559843329 creator A5079569047 @default.
• W2559843329 creator A5083653590 @default.
• W2559843329 date "2010-11-19" @default.
• W2559843329 modified "2023-10-16" @default.
• W2559843329 title "Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Ongoing Results of a Prospective Study" @default.
• W2559843329 doi "https://doi.org/10.1182/blood.v116.21.4704.4704" @default.
• W2559843329 hasPublicationYear "2010" @default.
• W2559843329 type Work @default.
• W2559843329 sameAs 2559843329 @default.
• W2559843329 citedByCount "0" @default.
• W2559843329 crossrefType "journal-article" @default.
• W2559843329 hasAuthorship W2559843329A5009276136 @default.
• W2559843329 hasAuthorship W2559843329A5015268079 @default.
• W2559843329 hasAuthorship W2559843329A5015623905 @default.
• W2559843329 hasAuthorship W2559843329A5016565948 @default.
• W2559843329 hasAuthorship W2559843329A5026698465 @default.
• W2559843329 hasAuthorship W2559843329A5028719318 @default.
• W2559843329 hasAuthorship W2559843329A5029820057 @default.
• W2559843329 hasAuthorship W2559843329A5030528628 @default.
• W2559843329 hasAuthorship W2559843329A5036597360 @default.
• W2559843329 hasAuthorship W2559843329A5038654360 @default.
• W2559843329 hasAuthorship W2559843329A5047806703 @default.
• W2559843329 hasAuthorship W2559843329A5047949241 @default.
• W2559843329 hasAuthorship W2559843329A5051875196 @default.
• W2559843329 hasAuthorship W2559843329A5060457186 @default.
• W2559843329 hasAuthorship W2559843329A5067333129 @default.
• W2559843329 hasAuthorship W2559843329A5079569047 @default.
• W2559843329 hasAuthorship W2559843329A5083653590 @default.
• W2559843329 hasConcept C104317684 @default.
• W2559843329 hasConcept C111289621 @default.
• W2559843329 hasConcept C126322002 @default.
• W2559843329 hasConcept C136449434 @default.
• W2559843329 hasConcept C150194340 @default.
• W2559843329 hasConcept C170493617 @default.
• W2559843329 hasConcept C190727270 @default.
• W2559843329 hasConcept C193419808 @default.
• W2559843329 hasConcept C203014093 @default.
• W2559843329 hasConcept C2776709828 @default.
• W2559843329 hasConcept C2778420691 @default.
• W2559843329 hasConcept C2779138994 @default.
• W2559843329 hasConcept C2779836521 @default.
• W2559843329 hasConcept C2781236682 @default.
• W2559843329 hasConcept C2911091166 @default.
• W2559843329 hasConcept C55493867 @default.
• W2559843329 hasConcept C71924100 @default.
• W2559843329 hasConcept C86803240 @default.
• W2559843329 hasConcept C8891405 @default.
• W2559843329 hasConcept C95444343 @default.
• W2559843329 hasConceptScore W2559843329C104317684 @default.
• W2559843329 hasConceptScore W2559843329C111289621 @default.
• W2559843329 hasConceptScore W2559843329C126322002 @default.
• W2559843329 hasConceptScore W2559843329C136449434 @default.
• W2559843329 hasConceptScore W2559843329C150194340 @default.
• W2559843329 hasConceptScore W2559843329C170493617 @default.
• W2559843329 hasConceptScore W2559843329C190727270 @default.
• W2559843329 hasConceptScore W2559843329C193419808 @default.
• W2559843329 hasConceptScore W2559843329C203014093 @default.
• W2559843329 hasConceptScore W2559843329C2776709828 @default.
• W2559843329 hasConceptScore W2559843329C2778420691 @default.
• W2559843329 hasConceptScore W2559843329C2779138994 @default.
• W2559843329 hasConceptScore W2559843329C2779836521 @default.
• W2559843329 hasConceptScore W2559843329C2781236682 @default.
• W2559843329 hasConceptScore W2559843329C2911091166 @default.
• W2559843329 hasConceptScore W2559843329C55493867 @default.
• W2559843329 hasConceptScore W2559843329C71924100 @default.
• W2559843329 hasConceptScore W2559843329C86803240 @default.
• W2559843329 hasConceptScore W2559843329C8891405 @default.
• W2559843329 hasConceptScore W2559843329C95444343 @default.
• W2559843329 hasLocation W25598433291 @default.
• W2559843329 hasOpenAccess W2559843329 @default.
• W2559843329 hasPrimaryLocation W25598433291 @default.
• W2559843329 hasRelatedWork W1488013057 @default.
• W2559843329 hasRelatedWork W1964133468 @default.
• W2559843329 hasRelatedWork W1978059263 @default.
• W2559843329 hasRelatedWork W1988502933 @default.
• W2559843329 hasRelatedWork W2014416623 @default.
• W2559843329 hasRelatedWork W2032253625 @default.
• W2559843329 hasRelatedWork W2050528176 @default.
• W2559843329 hasRelatedWork W2052417487 @default.
• W2559843329 hasRelatedWork W2064976912 @default.
• W2559843329 hasRelatedWork W2113947795 @default.
• W2559843329 hasRelatedWork W2168733379 @default.
• W2559843329 hasRelatedWork W2284984011 @default.

• next